Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Carboplatin + NKT3447 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Carboplatin | Paraplatin | CBDCA | Chemotherapy - Platinum 7 | Paraplatin (carboplatin) is a second-generation platinum compound and is activated intracellularly to form reactive platinum complexes that cross link DNA with DNA and with proteins. This induces apoptosis and inhibits cell growth (NCI Drug Dictionary). |
NKT3447 | NKT-3447|NKT 3447 | CDK2 Inhibitor 31 | NKT3447 selectively inhibits CDK2 and disrupts the CDK2/CCNE1 and CDK2/CCNA2 complexes, which results in decreased Ccne1 and inhibition of Rb1 phosphorylation, potentially leading to cell cycle arrest and inhibition of tumor growth (Cancer Res (2024) 84 (6_Supplement): 5705). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|